Intervention research on a reduction of upper limb spasticity

Phase 2

• Conditions: pper limb spasticity resulting from stroke; Upper limb spasticity

• Registration Number: JPRN-jRCTs032200164
• Lead Sponsor: Abo Masahiro

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-10-19
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

Targetting patients with upper limb spasticity as a result of aftereffects of stroke,
and who meet all of the following criteria, and who can obtain their consent;
1)Stroke sequelae patients with upper extremity spasticity between the ages of 20 and 80
2)More than 6 months have passed since the onset of stroke
3)Upper limb Brunstrom stage, which is an upper limb function evaluation, is 3-5
4)The general condition is stable
5)Patients who do not recognize cognitive impairment and can understand the research plan
6)Patients who received a sufficient explanation to participate in this study and, after a thorough understanding, obtained the written informed consent of the patient.
7)Regardless of gender
8)Patients who can visit the hospital according to the study schedule

Exclusion Criteria

Those who meet at least one of the following exclusion criteria will be excluded.
1)Patients with implantable medical devices (pacemakers or cochlear implants)
2) Patients with serious heart disease
3) Pregnant women or patients suspected of being pregnant
4) In addition, patients who are judged to be inappropriate to participate in this study by research responsible doctors or assigned doctors
5) Patients who are unstable or need immediate treatment (acute heart failure, acute renal failure, acute liver failure, severe diabetes, infectious disease, etc.)
6) Patients who participated in other clinical trials within 4 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified